Thermo Fisher lifts profit forecast as medical equipment demand improves

Go back to Thermo Fisher lifts profit forecast as medical equipment demand improves

Thermo Fisher Scientific (TMO) PT Raised to $610 at Deutsche Bank

April 25, 2024 6:16 AM EDT

Deutsche Bank analyst Justin Bowers raised the price target on Thermo Fisher Scientific (NYSE: TMO) to $610.00 (from $600.00) while maintaining a Buy rating.

The analyst comments "Messaging around bioprocessing was concise but positive, as order growth and book-to-bill continue to trend higher. We are... More